Pink SheetScripMedtech InsightHBW InsightGenerics BulletinIn Vivo

Spotlight

China
Obesity
AI
Drug Pricing
Cell & Gene Therapies

Business

Deals
Financing
Earnings
Commercial Strategy
Approvals & Launches
Trial Results
Market Access

Disease

Cancer
Immune Disorders
Cardiovascular
Neurological
Rare Diseases

Deep Dives

Interviews
Data Insights
Scrip Asks
Disease Landscapes

Focus On Asia

Japan
South Korea
India
Scrip Asia 100

Tools & Trackers

Pipeline Watch
Finance Watch
Deal Watch
Stock Watch
Top Selling Drugs
Company Rankings
Executive Moves

Conference Coverage

Partner InsightsOpens in new window

Scrip Perspectives

Previewing biopharma commercial, market access and development themes.

Medtech Insight

Generics Bulletin

GSK Bets Big On Its B7-H4 ADC With Five Phase III Trials Upcoming

Apr 12 2026

• By Aakash Babu

(Shutterstock)

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

Related Content

GSK Boosts ADC Heft Through Pact With Oxford BioTherapeutics

Dec 10 2025

GSK Doubles Down On B7-H3 ADCs

Oct 27 2025

GSK Bets On New Launches And R&D Acceleration As Sales Headwinds Remain

Feb 04 2026

Related Companies

GSK plc

AstraZeneca PLC

More from Trial Results

More from R&D

Twitter feed RSS feed RSS feed

About

About UsOpens in new window
Meet the Team
Editorial Standards
Award-Winning Journalism
Help
AdvertiseOpens in new window
Contact Us
Evaluate Home

Account

My Account
My View
Email Preferences
Start Free TrialOpens in new window

More

Scrip Perspectives
Scrip 100 Ranking
Scrip Asia 100
Conferences
Executives On The Move
Pipeline Watch

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window